Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTEST CORPINTT · Entity 6590 | Director | October 08, 2026 | October 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTEST CORP
Report date October 08, 2026 · Filed October 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,500 |
Ending reported balance
After 2026-10-09 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-10-08 · Gift · Disposed 36,000 · Balance 94,250 Row 2 · 2026-10-09 · Gift · Disposed 57,750 · Balance 36,500 |
| Common StockSEC Table I · non-derivative | IndirectBy Dews Family Trust | 93,750 |
Reported balance
Holding disclosure · report date 2026-10-08 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 93,750 F1: The reporting person and his spouse are co-trustees of the trust. The reporting person remains the beneficial owner of the shares of common stock held by the trust. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person and his spouse are co-trustees of the trust. The reporting person remains the beneficial owner of the shares of common stock held by the trust.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 09, 2026 Filed Oct 13, 2026 21:00 UTC | INTEST CORP INTT · Entity 6590 | GiftCommon Stock | 57,750 | $0.00 | $0.00 |
DisclosureSEC source: 0000891839-26-000470 · form4.xml · nonDerivative · entry 2 DEWS JOSEPH W IV · CIK 0001604939 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,500 Read SEC document |
| October 08, 2026 Filed Oct 13, 2026 21:00 UTC | INTEST CORP INTT · Entity 6590 | GiftCommon Stock | 36,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000891839-26-000470 · form4.xml · nonDerivative · entry 1 DEWS JOSEPH W IV · CIK 0001604939 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,250 Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 21:01 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000891839-26-000093 · form4.xml · nonDerivative · entry 1 DEWS JOSEPH W IV · CIK 0001604939 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,250 Read SEC document |
| May 12, 2025 Filed May 14, 2025 20:29 UTC | INTEST CORP INTT · Entity 6590 | PurchaseCommon Stock | 4,000 | $5.86 | $23,440.00 |
DisclosureSEC source: 0001062993-25-009372 · form4.xml · nonDerivative · entry 1 DEWS JOSEPH W IV · CIK 0001604939 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,250 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.80 to $5.92, inclusive. Mr. Dews undertakes to provide InTest Corporation, any security holder of InTest Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 23:56 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-005939 · form4.xml · nonDerivative · entry 1 DEWS JOSEPH W IV · CIK 0001604939 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,250 F1 · shares: The shares acquired are restricted shares issued pursuant to the inTEST Corporation 2023 Stock Incentive Plan and will vest on March 17, 2026. Read SEC document |
| August 14, 2024 Filed Aug 15, 2024 20:31 UTC | INTEST CORP INTT · Entity 6590 | PurchaseCommon Stock | 10,900 | $6.80 | $74,120.00 |
DisclosureSEC source: 0001062993-24-015173 · form4.xml · nonDerivative · entry 1 DEWS JOSEPH W IV · CIK 0001604939 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,250 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.77 to $6.80. The reporting person undertakes to provide inTEST Corporation, any security holder of inTEST Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: Includes 4,500 unvested restricted shares that vest in substantially equal installments on each of September 30, 2024 and December 31, 2024. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:33 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005994 · form4.xml · nonDerivative · entry 1 DEWS JOSEPH W IV · CIK 0001604939 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,350 F1 · shares: The shares acquired are restricted shares issued pursuant to the inTEST Corporation 2023 Stock Incentive Plan and will vest 25% on each of the following dates: March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. Read SEC document |
| June 12, 2023 Filed Jun 13, 2023 20:31 UTC | INTEST CORP INTT · Entity 6590 | SaleCommon Stock | 11,250 | $26.23 | $295,087.50 |
DisclosureSEC source: 0001062993-23-013414 · form4.xml · nonDerivative · entry 1 DEWS JOSEPH W IV · CIK 0001604939 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,350 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.10 to $26.65. Mr. Dews undertakes to provide inTEST Corporation, any security holder of inTEST Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:38 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-006631 · form4.xml · nonDerivative · entry 1 DEWS JOSEPH W IV · CIK 0001604939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,600 F1 · shares: The shares acquired are restricted shares issued pursuant to the Issuer's Fourth Amended and Restated 2014 Stock Plan and will vest 25% on each of the following dates: March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023. Read SEC document |
| May 09, 2022 Filed May 10, 2022 20:41 UTC | INTEST CORP INTT · Entity 6590 | PurchaseCommon Stock | 9,235 | $6.79 | $62,717.66 |
DisclosureSEC source: 0001036262-22-000013 · primary_doc.xml · nonDerivative · entry 1 DEWS JOSEPH W IV · CIK 0001604939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,600 F1 · price: The price reported is the weighted average purchase price of the shares bought in multiple transactions at prices ranging from $6.71 to $6.84, inclusive. Upon request, the reporting person will provide to the SEC, the issuer, or any security holder of the issuer full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 09, 2022 Filed Mar 10, 2022 22:23 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001036262-22-000002 · primary_doc.xml · nonDerivative · entry 1 DEWS JOSEPH W IV · CIK 0001604939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,365 F1 · shares: The shares acquired are restricted shares issued pursuant to the Issuer's Third Amended and Restated 2014 Stock Plan and will vest 25% on each of the following dates: March 31, 2022, June 30, 2022, September 30, 2022 and December 31, 2022. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 17:51 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001036262-21-000003 · primary_doc.xml · nonDerivative · entry 1 DEWS JOSEPH W IV · CIK 0001604939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,365 F1 · shares: The shares acquired are restricted shares issued pursuant to the Issuer's Third Amended and Restated 2014 Stock Plan and will vest 25% on each of the following dates: March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021. Read SEC document |
| November 17, 2020 Filed Nov 18, 2020 17:11 UTC | INTEST CORP INTT · Entity 6590 | PurchaseCommon Stock | 695 | $5.31 | $3,690.45 |
DisclosureSEC source: 0001036262-20-000013 · primary_doc.xml · nonDerivative · entry 7 DEWS JOSEPH W IV · CIK 0001604939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,365 Read SEC document |
| November 17, 2020 Filed Nov 18, 2020 17:11 UTC | INTEST CORP INTT · Entity 6590 | PurchaseCommon Stock | 400 | $5.20 | $2,080.00 |
DisclosureSEC source: 0001036262-20-000013 · primary_doc.xml · nonDerivative · entry 6 DEWS JOSEPH W IV · CIK 0001604939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,670 Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 17:11 UTC | INTEST CORP INTT · Entity 6590 | PurchaseCommon Stock | 4,712 | $5.20 | $24,502.40 |
DisclosureSEC source: 0001036262-20-000013 · primary_doc.xml · nonDerivative · entry 5 DEWS JOSEPH W IV · CIK 0001604939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,270 Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 17:11 UTC | INTEST CORP INTT · Entity 6590 | PurchaseCommon Stock | 100 | $5.19 | $519.00 |
DisclosureSEC source: 0001036262-20-000013 · primary_doc.xml · nonDerivative · entry 4 DEWS JOSEPH W IV · CIK 0001604939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,558 Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 17:11 UTC | INTEST CORP INTT · Entity 6590 | PurchaseCommon Stock | 620 | $5.15 | $3,193.00 |
DisclosureSEC source: 0001036262-20-000013 · primary_doc.xml · nonDerivative · entry 3 DEWS JOSEPH W IV · CIK 0001604939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,458 Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 17:11 UTC | INTEST CORP INTT · Entity 6590 | PurchaseCommon Stock | 2,800 | $5.10 | $14,280.00 |
DisclosureSEC source: 0001036262-20-000013 · primary_doc.xml · nonDerivative · entry 2 DEWS JOSEPH W IV · CIK 0001604939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,838 Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 17:11 UTC | INTEST CORP INTT · Entity 6590 | PurchaseCommon Stock | 38 | $5.05 | $191.90 |
DisclosureSEC source: 0001036262-20-000013 · primary_doc.xml · nonDerivative · entry 1 DEWS JOSEPH W IV · CIK 0001604939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,038 Read SEC document |
| March 09, 2020 Filed Mar 10, 2020 20:09 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001036262-20-000003 · primary_doc.xml · nonDerivative · entry 1 DEWS JOSEPH W IV · CIK 0001604939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,000 F1 · shares: The shares acquired are restricted shares issued pursuant to the Issuer's Second Amended and Restated 2014 Stock Plan and will vest 25% on each of the following dates: March 31, 2020, June 30, 2020, September 30, 2020 and December 31, 2020. Read SEC document |
| March 11, 2019 Filed Mar 13, 2019 21:23 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001036262-19-000008 · primary_doc.xml · nonDerivative · entry 1 DEWS JOSEPH W IV · CIK 0001604939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,000 F1 · shares: The shares acquired are restricted shares issued pursuant to the Issuer's Amended and Restated 2014 Stock Plan and will vest 25% on each of the following dates: March 31, 2019, June 30, 2019, September 30, 2019 and December 31, 2019. Read SEC document |
| March 12, 2018 Filed Mar 13, 2018 21:18 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001036262-18-000003 · primary_doc.xml · nonDerivative · entry 1 DEWS JOSEPH W IV · CIK 0001604939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,000 F1 · shares: The shares acquired are restricted shares issued pursuant to the Issuer's 2014 Stock Plan and will vest 25% on each of the following dates: March 31, 2018, June 30, 2018, September 30, 2018 and December 31, 2018. Read SEC document |
| March 15, 2017 Filed Mar 16, 2017 20:13 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001036262-17-000006 · primary_doc.xml · nonDerivative · entry 1 DEWS JOSEPH W IV · CIK 0001604939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 F1 · shares: The shares acquired are restricted shares issued pursuant to the Issuer's 2014 Stock Plan and will vest 25% immediately, and 25% on each of the following dates: June 30, 2017, September 30, 2017, and December 31, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.